Stewart D J, Baffour R
McGill University Centre for the Prevention of Cardiovascular Disease, Division of Cardiology, Royal Victoria Hospital, Montreal, Quebec, Canada.
Cardiovasc Res. 1990 Jan;24(1):7-12. doi: 10.1093/cvr/24.1.7.
STUDY OBJECTIVE - The aim was to study the effects of endothelin on the heart with special attention to an interaction with endothelium derived relaxing factor (EDRF). DESIGN - Bolus injections of various amounts of endothelin (1-300 ng) were given into the coronary circulation of isolated perfused rabbit hearts while coronary flow was held constant at 35 ml.min-1 and coronary perfusion pressure and other physiological variables were measured. The effects of indomethacin and haemoglobin on the responses were examined. EXPERIMENTAL MATERIAL - 15 New Zealand white rabbits, 1.0-1.5 kg, were used for the studies. The animals were anaesthetised and the hearts rapidly excised and perfused in the Langendorff manner. MEASUREMENTS and RESULTS - With coronary flow held constant, bolus injections of endothelin up to 300 ng caused no consistent increase in perfusion pressure, but resulted in a slight increase in left ventricular developed pressure. Indomethacin (10 microM) did not alter the response to endothelin; however, when endothelium dependent dilatation was inhibited by haemoglobin (10 microM), a dose dependent endothelin induced constriction was unmasked, with EC50 of 41 (SEM 15) ng, maximum +46(8) mm Hg. This constrictor response was further augmented by air infusion (0.5 ml), EC50 26(10) ng, maximum +102(12) mm Hg, and endothelin now caused a substantial dose dependent reduction in left ventricular contractile function. Endothelium dependent dilatation was not significantly reduced after air embolisation. CONCLUSIONS - The remarkable ability of the endothelium to protect against vasoconstrictor action of circulating endothelin in the coronary bed may not be due only to EDRF release, but perhaps also to an additional mechanism related to endothelial barrier of metabolic function.
研究目的——旨在研究内皮素对心脏的作用,特别关注其与内皮衍生舒张因子(EDRF)的相互作用。设计——在离体灌注兔心脏的冠脉循环中,以35 ml·min⁻¹恒定冠脉流量,分别快速推注不同剂量(1 - 300 ng)的内皮素,同时测量冠脉灌注压及其他生理变量。观察消炎痛和血红蛋白对这些反应的影响。实验材料——选用15只体重1.0 - 1.5 kg的新西兰白兔用于本研究。动物麻醉后,迅速取出心脏,以Langendorff方式进行灌注。测量与结果——在冠脉流量恒定的情况下,推注高达300 ng的内皮素不会使灌注压持续升高,但会使左心室舒张末压略有升高。消炎痛(10 μmol/L)不会改变对内皮素的反应;然而,当用血红蛋白(10 μmol/L)抑制内皮依赖性舒张时,可揭示出内皮素诱导的剂量依赖性收缩,半数有效浓度(EC50)为41(标准误15)ng,最大收缩压升高 +46(8) mmHg。空气注入(0.5 ml)可进一步增强这种收缩反应,EC50为26(10) ng,最大收缩压升高 +102(12) mmHg,此时内皮素可导致左心室收缩功能出现明显的剂量依赖性降低。空气栓塞后内皮依赖性舒张未显著降低。结论——在内皮在冠脉床中对抗循环内皮素的血管收缩作用的显著能力,可能不仅归因于EDRF的释放,还可能与内皮代谢功能屏障的额外机制有关。